Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
EDIT
EIKN
Add up to 3 more stocks
EDIT
Editas Medicine, Inc.
+2.34%
$2.86+0.07Delayed quote: Oct 6, 2026, 11:50 AM EDT
Market Cap
$438.18M
52W Range
$1.66 - $4.54
EIKN
Eikon Therapeutics, Inc. Common Stock
+1.86%
$7.68+0.14Delayed quote: Oct 6, 2026, 11:50 AM EDT
Market Cap
$415.78M
52W Range
$7.01 - $17.40
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 4.16 | 0.89 |
| P/S Ratio | 9.32 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 0.0% |
| Operating Margin | -245.2% | 0.0% |
| Net Margin | -157.3% | 0.0% |
| ROE | -70.2% | -69.1% |
| ROA | -31.1% | -41.3% |
| ROIC | -48.6% | -46.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.19 | 9.89 |
| Quick Ratio | 3.19 | 9.89 |
| Debt/Equity | 0.15 | 0.54 |
| Interest Coverage | -16.10 | -404.95 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.